Novel Isolongifolenone-Based Caprolactam Derivatives as Potential Anticancer Agents via the p53/mTOR/Autophagy Pathway.

新型异长叶烯酮基己内酰胺衍生物作为潜在的抗癌药物，通过 p53/mTOR/自噬途径发挥作用。